When does ABVC BIOPHARMA INC (ABVC) report earnings?
ABVC BIOPHARMA INC (ABVC) will report earnings on 2026-04-28.
ABVC BIOPHARMA INC (ABVC) Forecast, Price Target & Analyst Ratings
NASDAQ:ABVC • US00091F3047
Current stock price
1.1 USD
-0.04 (-3.51%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABVC BIOPHARMA INC (ABVC).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 28, 2026
- Period
- Q4 / 2025
- EPS Estimate
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $1.10 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
ABVC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ABVC.
In the previous month the buy percentage consensus was at a similar level.
ABVC was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-16 | Maxim Group | Downgrade | Buy -> Hold |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 28, 2026
- Period
- Q4 / 2025
- EPS Estimate
- N/A
- Revenue Estimate
- N/A
- Revenue Q2Q
- N/A
- EPS Q2Q
- N/A
- Number of Analysts
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
ABVC is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is 0 USD and the consensus revenue estimate is null USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 970K 169.44% | 152.4K -84.29% | 509.6K 234.38% | 4.256M -100.00% | |
| EBITDA YoY % growth | -15.09M -28.97% | -6.738M 55.35% | -4.673M 30.65% | N/A -52.49% | |
| EBIT YoY % growth | -15.11M -29.04% | -6.767M 55.22% | -4.705M 30.47% | -19.358M -51.99% | |
| Operating Margin | -1,557.73% | -4,440.09% | -923.31% | -454.83% | |
| EPS YoY % growth | N/A -126.09% | N/A 94.62% | N/A -57.14% | -0.47 -4.55% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | N/A |
| Revenue Q2Q % growth | N/A |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ABVC BIOPHARMA INC / ABVC Forecast FAQ
How do analysts rate ABVC BIOPHARMA INC (ABVC)?
The consensus rating for ABVC BIOPHARMA INC (ABVC) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.